Glutamine activates STAT3 to control cancer cell proliferation independently of glutamine metabolism

[1]  N. Pavlova,et al.  The Emerging Hallmarks of Cancer Metabolism. , 2016, Cell metabolism.

[2]  Eytan Ruppin,et al.  Glutamine Synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma , 2015, Nature Cell Biology.

[3]  P. Porporato,et al.  Inhibition of the pentose phosphate pathway by dichloroacetate unravels a missing link between aerobic glycolysis and cancer cell proliferation , 2015, Oncotarget.

[4]  T. Copetti,et al.  Lactate does not activate NF-κB in oxidative tumor cells , 2015, Front. Pharmacol..

[5]  S. Mittelman,et al.  Glutaminase activity determines cytotoxicity of L-asparaginases on most leukemia cell lines. , 2015, Leukemia research.

[6]  V. Poli,et al.  STAT3-Mediated Metabolic Reprograming in Cellular Transformation and Implications for Drug Resistance , 2015, Front. Oncol..

[7]  M. Dewhirst,et al.  Common responses of tumors and wounds to hypoxia. , 2015, Cancer journal.

[8]  Boris Ratnikov,et al.  Glutamate and asparagine cataplerosis underlie glutamine addiction in melanoma , 2015, Oncotarget.

[9]  Robert A. Egnatchik,et al.  Glutamate dehydrogenase 1 signals through antioxidant glutathione peroxidase 1 to regulate redox homeostasis and tumor growth. , 2015, Cancer cell.

[10]  V. Chandra,et al.  Effects of deranged metabolism on epigenetic changes in cancer , 2015, Archives of Pharmacal Research.

[11]  K. Guan,et al.  Differential regulation of mTORC1 by leucine and glutamine , 2015, Science.

[12]  D. Ann,et al.  Intermediary Metabolite Precursor Dimethyl-2-Ketoglutarate Stabilizes Hypoxia-Inducible Factor-1α by Inhibiting Prolyl-4-Hydroxylase PHD2 , 2014, PloS one.

[13]  Hua Yu,et al.  Revisiting STAT3 signalling in cancer: new and unexpected biological functions , 2014, Nature Reviews Cancer.

[14]  H. Lincet,et al.  How do glycolytic enzymes favour cancer cell proliferation by nonmetabolic functions? , 2014, Oncogene.

[15]  M. Follettie,et al.  Glutamine deprivation stimulates mTOR-JNK-dependent chemokine secretion , 2014, Nature Communications.

[16]  W. Burns,et al.  Cell surface lactate receptor GPR81 is crucial for cancer cell survival. , 2014, Cancer research.

[17]  N. Hay,et al.  The pentose phosphate pathway and cancer. , 2014, Trends in biochemical sciences.

[18]  T. Copetti,et al.  Glucose deprivation increases monocarboxylate transporter 1 (MCT1) expression and MCT1-dependent tumor cell migration , 2014, Oncogene.

[19]  M. Campbell,et al.  Nuclear receptors and the Warburg effect in cancer , 2014, International journal of cancer.

[20]  Prahlad T. Ram,et al.  Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer , 2014, Molecular systems biology.

[21]  F. Janku,et al.  STAT3 inhibitors: finding a home in lymphoma and leukemia. , 2014, The oncologist.

[22]  A. Bishayee,et al.  Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors. , 2014, Biochimica et biophysica acta.

[23]  M. Pawlus,et al.  STAT3 and HIF1α cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells , 2014, Oncogene.

[24]  V. Mastorodemos,et al.  The Odyssey of a Young Gene: Structure–Function Studies in Human Glutamate Dehydrogenases Reveal Evolutionary-Acquired Complex Allosteric Regulation Mechanisms , 2014, Neurochemical Research.

[25]  Bonnie F. Sloane,et al.  Metabotropic Glutamate Receptor-1 Contributes to Progression in Triple Negative Breast Cancer , 2014, PloS one.

[26]  D. Levy,et al.  The MEK-ERK Pathway Is Necessary for Serine Phosphorylation of Mitochondrial STAT3 and Ras-Mediated Transformation , 2013, PloS one.

[27]  Ralph J DeBerardinis,et al.  Glutamine and cancer: cell biology, physiology, and clinical opportunities. , 2013, The Journal of clinical investigation.

[28]  Shimin Zhao,et al.  Regulatory roles of metabolites in cell signaling networks. , 2013, Journal of genetics and genomics = Yi chuan xue bao.

[29]  Christian M. Metallo,et al.  Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells , 2013, Nature.

[30]  J. Matés,et al.  Glutaminase isoenzymes as key regulators in metabolic and oxidative stress against cancer. , 2013, Current molecular medicine.

[31]  R. Tomasini,et al.  Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma , 2013, Proceedings of the National Academy of Sciences.

[32]  P. Massion,et al.  SLC1A5 Mediates Glutamine Transport Required for Lung Cancer Cell Growth and Survival , 2012, Clinical Cancer Research.

[33]  J. Verrax,et al.  Lactate Activates HIF-1 in Oxidative but Not in Warburg-Phenotype Human Tumor Cells , 2012, PloS one.

[34]  B. Groner.  Determinants of the extent and duration of STAT3 signaling , 2012, JAK-STAT.

[35]  Y. Samuels,et al.  Molecular Pathways: Dysregulated Glutamatergic Signaling Pathways in Cancer , 2012, Clinical Cancer Research.

[36]  Christian M. Metallo,et al.  Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia , 2011, Nature.

[37]  C. Thompson,et al.  Glutamine addiction: a new therapeutic target in cancer. , 2010, Trends in biochemical sciences.

[38]  G. Semenza.  HIF-1: upstream and downstream of cancer metabolism. , 2010, Current opinion in genetics & development.

[39]  R. Deberardinis,et al.  Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling. , 2009, Cancer research.

[40]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[41]  Jeffrey P. MacKeigan,et al.  Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy , 2009, Cell.

[42]  Anthony Mancuso,et al.  Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction , 2008, Proceedings of the National Academy of Sciences.

[43]  Julien Verrax,et al.  Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. , 2008, The Journal of clinical investigation.

[44]  S. Yokoyama,et al.  Crystal structure of glutamine receptor protein from Sulfolobus tokodaii strain 7 in complex with its effector l-glutamine: implications of effector binding in molecular association and DNA binding , 2008, Nucleic acids research.

[45]  Hua Yu,et al.  Signal Transducer and Activator of Transcription 3 Is Required for Hypoxia-Inducible Factor-1α RNA Expression in Both Tumor Cells and Tumor-Associated Myeloid Cells , 2008, Molecular Cancer Research.

[46]  N. Curthoys,et al.  Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES). , 2007, The Biochemical journal.

[47]  Bianca Sperl,et al.  Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. , 2006, Chemistry & biology.

[48]  V. Avramis,et al.  Asparaginase (native ASNase or pegylated ASNase) in the treatment of acute lymphoblastic leukemia , 2006, International journal of nanomedicine.

[49]  A. Halestrap,et al.  The Plasma Membrane Lactate Transporter MCT4, but Not MCT1, Is Up-regulated by Hypoxia through a HIF-1α-dependent Mechanism* , 2006, Journal of Biological Chemistry.

[50]  T. Nakano,et al.  Higher Concentrations of Extracellular ATP Suppress Proliferation of Caco-2 Human Colonic Cancer Cells via an Unknown Receptor Involving PKC Inhibition , 2006, Cellular Physiology and Biochemistry.

[51]  G. Semenza,et al.  Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways , 2005, Oncogene.

[52]  S. Bröer,et al.  The low-affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells. , 2000, The Biochemical journal.

[53]  Pavel Kovarik,et al.  Serine phosphorylation of STATs , 2000, Oncogene.

[54]  W. Jelkmann,et al.  Pericellular PO2 and O2 consumption in monolayer cell cultures. , 1995, Respiration physiology.

[55]  J. Darnell,et al.  Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. , 1994, Science.

[56]  H. Bosmann,et al.  The intrinsic glutaminase activity of asparaginase: cytotoxicity and cellular resistance. , 1979, Research communications in chemical pathology and pharmacology.

[57]  L. Reitzer,et al.  Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. , 1979, The Journal of biological chemistry.

[58]  P. Fürst,et al.  Intracellular free amino acid concentration in human muscle tissue. , 1974, Journal of applied physiology.

[59]  A. Pinto,et al.  Molecular and Cellular Pathobiology The SIRT 1 / HIF 2 a Axis Drives Reductive Glutamine Metabolism under Chronic Acidosis and Alters Tumor Response to Therapy , 2014 .

[60]  이연수.  Functional genomics reveal that the serine synthesis pathway is essential in breast cancer , 2011 .

[61]  Lisa L. Smith,et al.  AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity. , 2010, Cancer research.

[62]  R. Rossignol,et al.  Mitochondria: from bioenergetics to the metabolic regulation of carcinogenesis. , 2009, Frontiers in bioscience.

[63]  J. Avruch,et al.  Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR , 2000, Current Biology.

[64]  J. Turkson,et al.  Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. , 1999, Immunity.